| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥1.7B | ¥1.6B | +2.0% |
| Operating Income | ¥-2.8B | ¥-3.3B | +15.3% |
| Ordinary Income | ¥-3.1B | ¥-3.7B | +15.6% |
| Net Income | ¥-2.5B | ¥-4.0B | +36.2% |
| ROE | -25.4% | -155.7% | - |
FY2026 Q2 results show continued losses with modest improvement. Revenue reached 1.7B yen (+2.0% YoY), while operating loss narrowed to -2.8B yen (improved 15.3% from -3.3B yen YoY). Ordinary loss improved 15.6% to -3.1B yen from -3.7B yen, and net loss decreased 36.2% to -2.5B yen from -4.0B yen YoY. The loss reduction was supported by extraordinary gain on sale of securities of 0.6B yen. Despite incremental revenue growth, the company faces structural profitability challenges with negative gross margin of -18.1% and SG&A expenses at 148.5% of revenue. Operating cash flow deteriorated significantly to -10.7B yen (-186.6% YoY), while equity base strengthened substantially to 10.0B yen from 2.5B yen, primarily through equity financing of approximately 9.9B yen.
Revenue increased 2.0% YoY to 1.7B yen, driven primarily by the MS (formerly MX) segment which generated 1.65B yen in revenue (+3.9% from prior period 1.59B yen). The EX segment contributed minimal revenue of 9 million yen, declining from 38 million yen YoY. The revenue growth occurred against a backdrop of structural cost challenges, as cost of sales reached 2.0B yen, exceeding revenue and resulting in negative gross profit of -0.3B yen with gross margin of -18.1%. This indicates fundamental issues in unit economics and pricing power. SG&A expenses remained elevated at 2.5B yen (148.5% of revenue), declining slightly from 2.6B yen in the prior period but still consuming substantially more than revenue generation. The combined effect produced operating loss of -2.8B yen, representing an operating margin of -166.3%, though improved from -201.9% YoY. Non-operating expenses totaled 0.4B yen, primarily comprising interest expense of 0.1B yen and other non-operating costs, widening ordinary loss to -3.1B yen. The gap between operating loss (-2.8B yen) and ordinary loss (-3.1B yen) of approximately -0.3B yen reflects net non-operating costs. Extraordinary items provided significant support: gain on sale of securities contributed 0.6B yen while extraordinary losses totaled 0.2B yen, resulting in net extraordinary gain of 0.4B yen. This non-recurring benefit reduced profit before tax to -2.5B yen and final net loss to -2.5B yen after minimal tax impact. The net loss improvement of 36.2% YoY from -4.0B yen was partly attributable to this non-recurring gain. Basic EPS improved 81.4% to -10.64 yen from -57.31 yen, also benefiting from increased share count (average shares outstanding 23.8M). This represents a revenue up/loss down pattern, where modest top-line growth failed to translate into bottom-line improvement in core operations, with loss reduction dependent on non-recurring gains.
MS segment (core business representing 99.4% of revenue) generated revenue of 1.65B yen with operating loss of -0.64B yen, resulting in negative margin of -38.9%. This represents deterioration from prior period operating loss of -0.20B yen despite revenue growth, suggesting cost structure challenges intensified. The segment absorbed unallocated corporate costs of -2.12B yen (increased from -1.36B yen YoY). EX segment contributed minimal revenue of 9 million yen (0.5% of total) with operating profit of 2 million yen and positive margin of 21.3%, improving from prior period operating loss of -1.71B yen. The dramatic turnaround in EX segment profitability occurred alongside sharp revenue decline, suggesting cost rationalization or business model shift. The MS segment clearly represents the core business but currently operates at substantial loss before corporate cost allocation. Corporate unallocated costs increased 55.8% YoY, indicating overhead burden expanded faster than revenue base. The profitability gap between segments highlights that MS segment faces both direct operational challenges (negative segment profit) and absorption of growing corporate overhead.
[Profitability] ROE of -25.4% reflects loss-making operations, with negative net profit margin of -152.4% and operating margin of -166.3%. DuPont decomposition shows net margin as the primary driver of negative ROE, followed by low asset turnover of 0.083, partially offset by financial leverage of 2.01x. The negative gross margin of -18.1% indicates fundamental business model issues where cost of sales exceeds revenue. Return on assets stood at -12.7% and return on invested capital at -27.7%, both reflecting capital inefficiency. [Cash Quality] Cash conversion ratio stood at 4.24x (operating CF to net income), though this reflects deeper operating cash outflow relative to accounting loss rather than quality improvement. Operating cash flow to revenue ratio was -6.44x, indicating substantial cash consumption. [Investment Efficiency] Asset turnover of 0.083 indicates each yen of assets generated only 8.3 sen of revenue, well below efficient utilization. CapEx to depreciation ratio of 39.5x suggests aggressive investment relative to asset base. [Financial Health] Equity ratio improved significantly to 49.8% from 13.2% YoY, driven by equity capital injection. Current ratio data shows 7.74x based on available information, indicating adequate short-term coverage. Debt-to-equity ratio remained moderate, though operating losses continue to pressure capital base absent external funding.
Operating cash flow deteriorated sharply to -10.7B yen from -1.2B yen YoY (-786.6% change), representing -6.4x of revenue and 4.2x of net loss magnitude. This indicates cash consumption exceeded accounting losses, with working capital movements and non-cash adjustments amplifying outflows. Operating subtotal before working capital stood at -10.7B yen, with inventory changes contributing positive 0.2B yen while receivables increased by 1.3B yen, consuming cash. Payables remained essentially flat with minimal change. Income taxes paid were negligible at -0.03B yen and interest paid totaled -0.1B yen. Investing cash flow recorded -12.4B yen, primarily driven by capital expenditures of -6.9B yen and other investment activities. The aggressive CapEx represents 4.2x revenue, suggesting significant facility or infrastructure development. Free cash flow reached -23.1B yen, indicating inability to self-fund operations and investments. Financing cash flow provided +8.7B yen, substantially from equity issuance of approximately 9.9B yen with minimal debt movements. The overall cash position decreased 14.4B yen during the period to 2.9B yen from 17.3B yen, representing 83.4% drawdown of opening cash. This cash consumption rate raises concerns about runway length despite equity injection, as current burn rate would exhaust remaining cash within one quarter absent further funding or operational improvement.
Ordinary income of -3.1B yen versus operating income of -2.8B yen shows non-operating net expense of approximately 0.3B yen, comprising interest expense of 0.1B yen and other financial costs. Non-operating expenses represent 18% of revenue. Extraordinary items had material impact with gain on sale of securities of 0.6B yen and extraordinary losses of 0.2B yen, contributing net extraordinary gain of 0.4B yen equal to 24% of revenue. This non-recurring benefit masked underlying operational deterioration and accounts for the majority of net loss improvement versus operating loss. Earnings quality is compromised by negative gross margins, high accruals ratio of 41.0%, and operating cash flow substantially negative at -10.7B yen versus net loss of -2.5B yen. The cash outflow exceeding accounting loss by 4.2x indicates aggressive accrual accounting, working capital build, or investment timing effects. Interest coverage ratio of -18.8x reflects negative EBIT relative to interest burden, indicating inability to service debt from operations. EBIT margin of -166.3% and ROIC of -27.7% both trigger quality warning thresholds. The reliance on extraordinary gains (securities sales) and equity financing rather than operational improvement raises sustainability concerns regarding reported loss reduction.
Annual dividend forecast remains at 0.00 yen with no dividend revisions during the quarter. The company maintains a no-dividend policy given ongoing losses and negative free cash flow of -23.1B yen. Payout ratio is not applicable given net losses. No share buyback activities were disclosed. Total shareholder returns remain at zero, with capital allocation focused entirely on business investment and working capital needs. Given operating cash flow of -10.7B yen and free cash flow of -23.1B yen, dividend capacity is absent and resumption would require sustained return to profitability and positive cash generation. Share count increased to 27.1M outstanding shares from equity issuance, resulting in dilution of approximately 13.7% during the period based on average shares.
Structural profitability deficit with gross margin of -18.1% and operating margin of -166.3% indicates the business model currently destroys value on each sale, requiring fundamental restructuring of pricing or cost structure. Failure to achieve breakeven gross margins would necessitate continued external funding and risk business continuity.
Operating cash consumption of -10.7B yen against cash reserves of 2.9B yen provides approximately 0.27 quarters of runway at current burn rate. While recent equity raise of 9.9B yen provided temporary relief, persistent cash outflows at this magnitude create refinancing risk and potential dilution from future capital raises if operational improvement does not materialize.
High investment intensity with CapEx of -6.9B yen (4.2x revenue) creates execution risk that invested capital fails to generate adequate returns. ROIC of -27.7% indicates current investments are not creating value, and delayed or insufficient payback from recent capital deployment would compound liquidity pressures.
[Industry Position] (Reference - Proprietary Analysis)
The company's performance significantly lags IT/Telecom industry benchmarks across key metrics. Profitability shows ROE of -25.4% versus industry median of 5.6%, operating margin of -166.3% versus industry median of 14.0%, and net profit margin of -152.6% versus industry median of 9.2%. The negative profitability profile places the company well below the 25th percentile of peer performance. Efficiency metrics reveal asset turnover of 0.083 versus industry median of 0.35, indicating substantially lower capital productivity at approximately 24% of peer levels. Financial leverage of 2.01x slightly exceeds industry median of 1.55x despite recent equity injection. Revenue growth of 2.0% YoY significantly trails industry median growth of 21.0%, positioning in the bottom quartile for top-line expansion (industry IQR: 15.5%-26.8%). Financial health shows equity ratio of 49.8% approaching industry median of 60.2% following capital raise, though still below median. The Rule of 40 metric (revenue growth + profit margin) stands at approximately -150% versus industry median of 31%, reflecting simultaneous challenges in both growth velocity and profitability. Return on invested capital of -27.7% compares unfavorably to industry median ROIC of 11%, indicating structural capital efficiency issues. These comparisons suggest the company operates as a distressed or early-stage entity within a generally healthy industry, with performance gaps indicating need for fundamental business model revision rather than incremental optimization.
※ Industry: IT/Telecom (7 companies), Comparison: Prior fiscal periods, Source: Proprietary analysis
The company demonstrates a business in restructuring phase rather than sustainable growth trajectory, evidenced by three consecutive data points of structural challenges. First, negative unit economics persist with gross margin of -18.1%, meaning the core business destroys value before overhead allocation, requiring fundamental repricing or cost restructuring rather than scale solutions. Second, cash consumption accelerated to -10.7B yen operating CF despite loss reduction in accounting terms, indicating working capital intensity or investment timing creates material divergence between reported earnings and economic reality, with accruals ratio of 41.0% flagging aggressive accounting assumptions. Third, the business model currently operates at 4.2x revenue capital intensity (CapEx to revenue) while generating negative returns (ROIC -27.7%), suggesting a capital-intensive buildout phase that has not yet demonstrated proof of concept for return generation.
The equity injection of approximately 9.9B yen provided temporary liquidity relief but created approximately 13.7% dilution, and at current burn rates of -23B yen free cash flow, positions the company for potential additional dilutive financing within 2-3 quarters absent material operational inflection. The MS segment renaming from MX segment alongside simultaneous profitability deterioration (-0.64B yen loss versus -0.20B yen prior) despite revenue growth suggests possible business model pivot or market repositioning that has not yet stabilized.
Observable from the earnings data: the 36.2% net loss improvement was substantially aided by 0.6B yen non-recurring securities gains (representing 24% of narrowed loss), while underlying operating performance deteriorated with corporate costs increasing 55.8% YoY outpacing 2.0% revenue growth, indicating cost structure mismatch with revenue base and questioning sustainability of reported improvements without continued asset monetization or operational turnaround.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.